Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease.
Jiang S, Wang H, Yang C, Feng F, Xu D, Zhang M, Xie M, Cui R, Zhu Z, Jia C, Liu L, Wang L, Yang X, Yang Y, Hao H, Liu Z, Wu Z, Leng L, Li X, Sun X, Zhao X, Xu J, Zhang Y, Wan X, Bao X, Wang R.
Jiang S, et al. Among authors: zhao x.
J Neurol Neurosurg Psychiatry. 2024 May 9:jnnp-2023-332921. doi: 10.1136/jnnp-2023-332921. Online ahead of print.
J Neurol Neurosurg Psychiatry. 2024.
PMID: 38724232
Intranasal transplantation of neural stem cells represents a new avenue for the treatment of PD, and a larger, longer-term, randomised, controlled phase 2 trial is warranted for further investigation....
Intranasal transplantation of neural stem cells represents a new avenue for the treatment of PD, and a larger, longer-term, randomise …